Q1 2026 TU
Logotype for Exasol AG

Exasol (EXL) Q1 2026 TU earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Exasol AG

Q1 2026 TU earnings summary

15 May, 2026

Executive summary

  • Q1 2026 revenue was €9.5 million, down from €12.4 million in Q1 2025, mainly due to the absence of a one-time deal and non-recurring revenue items in the prior year.

  • Annual Recurring Revenue (ARR) declined 3.5% year-over-year to €37.8 million, but improved from Q4 2025, with churn returning to more typical levels and new logo momentum building.

  • EBITDA for Q1 2026 was €0.4 million, down from €1.3 million in Q1 2025, impacted by higher marketing expenses and lower non-recurring revenue.

  • Net liquid funds increased to €24.7 million at quarter-end, up from €18.7 million year-over-year, providing operational flexibility.

  • Guidance for FY2026 is confirmed, with expectations for ARR growth in the second half of the year.

Financial highlights

  • FY 2025 audited revenue was €41.8 million, up from €39.6 million in FY 2024; recurring revenue declined to €37.7 million from €39.1 million.

  • Non-recurring revenue in FY 2025 was €4.1 million, a significant increase from €0.5 million in FY 2024.

  • Gross profit margin for FY 2025 was 92%, down from 100% in FY 2024.

  • FY 2025 EBITDA was €4.1 million (9.7% margin), up from €2.0 million (5.1% margin) in FY 2024.

  • FY 2025 net income was €3.0 million, up from €0.2 million in FY 2024.

Outlook and guidance

  • ARR growth for 2026 is guided to be in the mid-single-digit percentage range, reversing the -8.0% decline in 2025.

  • Revenue is expected to decline in the mid-single-digit percentage range in 2026 due to the lack of large one-off deals.

  • EBITDA guidance for 2026 remains at €3.0–4.0 million.

  • Churn rate is expected to further normalize toward 10% or lower over the year.

  • Foundation laid for ARR growth in the second half of 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more